Monday, 20 May 2013
 
  • Home
  • About
    • Top Down Proteomics
      • Publication Metrics
      • Publication Metrics (Cumulative)
    • Consortium
      • Timeline
      • Leadership
      • Investigators
      • Sponsors
    • Contact Us
  • News
    • Conferences
    • Feeds
    • Publications
  • Repository
  • Q & A
    • Separations
    • Mass Spectrometry
    • Data Analysis
  • Tutorials
    • Separations
    • Mass Spectrometry
    • Data Analysis
  • Software
  • Login
    • Become a Member
feed-image

GMU Team Builds Phosphoproteomic-based Pathway Activation Profiles of NCI-60 Cancer Cell Lines

 

read more

GMU Team Builds Phosphoproteomic-based Pathway Activation Profiles of NCI-60 Cancer Cell LinesGMU Team Builds Phosphoproteomic-based Pathway Activation Profiles of NCI-60 Cancer Cell LinesGMU Team Builds Phosphoproteomic-based Pathway Activation Profiles of NCI-60 Cancer Cell LinesGMU Team Builds Phosphoproteomic-based Pathway Activation Profiles of NCI-60 Cancer Cell LinesGMU Team Builds Phosphoproteomic-based Pathway Activation Profiles of NCI-60 Cancer Cell Lines
...

Continue Reading

Researchers Devise Fast MS Proteome Profiling Workflow for Use in Chinese Human Proteome Project

 

read more

Researchers Devise Fast MS Proteome Profiling Workflow for Use in Chinese Human Proteome ProjectResearchers Devise Fast MS Proteome Profiling Workflow for Use in Chinese Human Proteome ProjectResearchers Devise Fast MS Proteome Profiling Workflow for Use in Chinese Human Proteome ProjectResearchers Devise Fast MS Proteome Profiling Workflow for Use in Chinese Human Proteome ProjectResearchers Devise Fast MS Proteome Profiling Workflow for Use in Chinese Human Proteome Project
...

Continue Reading

Vermillion Posts 8 Percent Increase in OVA1 Sales, Announces Shift in Commercialization Strategy

 

read more

Vermillion Posts 8 Percent Increase in OVA1 Sales, Announces Shift in Commercialization StrategyVermillion Posts 8 Percent Increase in OVA1 Sales, Announces Shift in Commercialization StrategyVermillion Posts 8 Percent Increase in OVA1 Sales, Announces Shift in Commercialization StrategyVermillion Posts 8 Percent Increase in OVA1 Sales, Announces Shift in Commercialization StrategyVermillion Posts 8 Percent Increase in OVA1 Sales, Announces Shift in Commercialization Strategy
...

Continue Reading

Funding Update: NIH Grants Awarded to UCLA, Cold Spring Harbor, and More

Funding Update: NIH Grants Awarded to UCLA, Cold Spring Harbor, and More

 

read more

Funding Update: NIH Grants Awarded to UCLA, Cold Spring Harbor, and MoreFunding Update: NIH Grants Awarded to UCLA, Cold Spring Harbor, and MoreFunding Update: NIH Grants Awarded to UCLA, Cold Spring Harbor, and MoreFunding Update: NIH Grants Awarded to UCLA, Cold Spring Harbor, and MoreFunding Update: NIH Grants Awarded to UCLA, Cold Spring Harbor, and More
...

Continue Reading

New Products: Agilent, Thermo Fisher Scientific

 

read more

New Products: Agilent, Thermo Fisher ScientificNew Products: Agilent, Thermo Fisher ScientificNew Products: Agilent, Thermo Fisher ScientificNew Products: Agilent, Thermo Fisher ScientificNew Products: Agilent, Thermo Fisher Scientific
...

Continue Reading

People in the News: Bruker, Waters

 

read more

People in the News: Bruker, WatersPeople in the News: Bruker, WatersPeople in the News: Bruker, WatersPeople in the News: Bruker, WatersPeople in the News: Bruker, Waters
...

Continue Reading

25(th) ASMS Sanibel Conference on Top Down Mass Spectrometry.

Related Articles
...

Continue Reading

GenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the Clinic

image

 

read more

GenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the ClinicGenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the ClinicGenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the ClinicGenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the ClinicGenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the Clinic
...

Continue Reading

Using Somalogic Aptamer Tech, Harvard Team Finds Protein That Reverses Age-related Heart Disease in Mice

 

read more

Using Somalogic Aptamer Tech, Harvard Team Finds Protein That Reverses Age-related Heart Disease in MiceUsing Somalogic Aptamer Tech, Harvard Team Finds Protein That Reverses Age-related Heart Disease in MiceUsing Somalogic Aptamer Tech, Harvard Team Finds Protein That Reverses Age-related Heart Disease in MiceUsing Somalogic Aptamer Tech, Harvard Team Finds Protein That Reverses Age-related Heart Disease in MiceUsing Somalogic Aptamer Tech, Harvard Team Finds Protein That Reverses Age-related Heart Disease in Mice
...

Continue Reading

More Articles...

  • UW-Madison Researchers Demonstrate Potential of Custom Search Databases in Mass Spec Proteomics
  • Funding Update: NSF Grants Awarded to University of Michigan
  • New Products: DVS Sciences, Biognosys
12345678910»End

Discover | Experiment | Contribute

Consortium for Top Down Proteomics | 2205 Tech Drive | Evanston, IL 60208
Phone: 847.467.1076 | Fax: 847.467.3276 | info@topdownproteomics.org
© 2013 Consortium for Top Down Proteomics | All Rights Reserved | Montano Designs